Authors:
LUTZ MW
MORGAN PH
KENAKIN TP
GOETZ A
QUEEN K
IRVING P
ROSE D
GILL JM
RIMELE T
Citation: Mw. Lutz et al., A MATHEMATICAL-MODEL FOR ANALYSIS OF PHARMACOLOGICALLY INDUCED CHANGES IN THE KINETICS OF CARDIAC-MUSCLE, Journal of pharmacological and toxicological methods, 36(3), 1996, pp. 171-183
Citation: Jm. Weiss et al., THE CUBIC TERNARY COMPLEX RECEPTOR-OCCUPANCY MODEL .3. RESURRECTING EFFICACY, Journal of theoretical biology, 181(4), 1996, pp. 381-397
Citation: Jm. Weiss et al., THE CUBIC TERNARY COMPLEX RECEPTOR-OCCUPANCY MODEL .1. MODEL DESCRIPTION, Journal of theoretical biology, 178(2), 1996, pp. 151-167
Citation: Jm. Weiss et al., THE CUBIC TERNARY COMPLEX RECEPTOR-OCCUPANCY MODEL .2. UNDERSTANDING APPARENT AFFINITY, Journal of theoretical biology, 178(2), 1996, pp. 169-182
Authors:
SAUSSY DL
GOETZ AS
QUEEN KL
KING HK
LUTZ MW
RIMELE TJ
Citation: Dl. Saussy et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF A SERIES OF BUSPIRONE ANALOGS AT ALPHA-1-ADRENOCEPTORS - FURTHER EVIDENCE THAT RAT AORTA ALPHA-1-ADRENOCEPTORS ARE OF THE ALPHA-1D-SUBTYPE, The Journal of pharmacology and experimental therapeutics, 278(1), 1996, pp. 136-144
Authors:
LUTZ MW
KENAKIN TP
CORSI M
MENIUS JA
KRISHNAMOORTHY C
RIMELE T
MORGAN PH
Citation: Mw. Lutz et al., USE OF RESAMPLING TECHNIQUES TO ESTIMATE THE VARIANCE OF PARAMETERS IN PHARMACOLOGICAL ASSAYS WHEN EXPERIMENTAL PROTOCOLS PRECLUDE INDEPENDENT REPLICATION - AN EXAMPLE USING SCHILD REGRESSIONS, Journal of pharmacological and toxicological methods, 34(1), 1995, pp. 37-46
Citation: As. Goetz et al., CHARACTERIZATION OF ALPHA-1-ADRENOCEPTOR SUBTYPES IN HUMAN AND CANINEPROSTATE MEMBRANES, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1228-1233
Authors:
LUTZ MW
MORGAN PH
JAMES MK
FELDMAN PL
BRACKEEN MF
LAHEY AP
JAMES SV
BILOTTA JM
PRESSLEY JC
Citation: Mw. Lutz et al., A PHARMACODYNAMIC MODEL TO INVESTIGATE THE STRUCTURE-ACTIVITY PROFILEOF A SERIES OF NOVEL OPIOID ANALGESICS, The Journal of pharmacology and experimental therapeutics, 271(2), 1994, pp. 795-803